4//SEC Filing
Harsch Mutya 4
Accession 0001209191-23-058817
CIK 0001566044other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 5:09 PM ET
Size
8.1 KB
Accession
0001209191-23-058817
Insider Transaction Report
Form 4
Harsch Mutya
CHIEF LEGAL OFFICER AND GC
Transactions
- Award
Common Stock
2023-12-13+62,500→ 87,096 total - Award
Stock Option (right to buy)
2023-12-13+62,500→ 62,500 totalExercise: $2.70Exp: 2033-12-12→ Common Stock (62,500 underlying)
Footnotes (3)
- [F1]Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.
- [F3]The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001727809
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 5:09 PM ET
- Size
- 8.1 KB